2 recruiting, 1 completed, 1 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Amydis Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AMDX-2011P in Participants With Alzheimer's Disease AMDX-2011P - Alzheimer Disease | Phase 2 | Recruiting | Amydis Inc. | 25 | 2025-03-07 | 2026-08-31 |
| A Study of AMDX-2011P in Participants With CAA AMDX-2011P - Cerebral Amyloid Angiopathy | Phase 2 | Recruiting | Amydis Inc. | 25 | 2024-07-09 | 2026-02-13 |
| A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma AMDX-2011P - Primary Open Angle Glaucoma | Phase 2 | Unknown | Amydis Inc. | 50 | 2023-12-07 | 2024-07-30 |
| Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy AMDX2011P - Parkinson Disease, Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Completed | Amydis Inc. | 13 | 2022-08-24 | 2025-08-20 |
Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Cerebral Amyloid Angiopathy (1) · Glaucoma, Open-Angle (1) · Parkinson Disease (1)
United States (4)
David Bingaman (1) · Masoud Mokhtarani, MD (1)